Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedDec 27, 2017NitroGlycerinStability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.Advanced Pharma Inc. · D-0119-2018Class IITerminatedDec 27, 2017NitroGlycerinStability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.Advanced Pharma Inc. · D-0118-2018Class IITerminatedDec 27, 2017NitroGlycerin 100 mcg/mL QS 5% Dextrose InjStability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.Advanced Pharma Inc. · D-0117-2018Class IITerminatedDec 27, 2017NitroGlycerin 1 mg/10 mL in 5% Dextrose InjStability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.Advanced Pharma Inc. · D-0116-2018Class ITerminatedDec 27, 2017NitroGlycerinSubpotent Drug: found to be below the specification for labeled assay.Advanced Pharma Inc. · D-0115-2018Class ITerminatedDec 27, 2017NitroGlycerinSubpotent Drug: found to be below the specification for labeled assay.Advanced Pharma Inc. · D-0114-2018Class ITerminatedDec 27, 2017NitroGlycerin 1 mg/10 mL in 5% Dextrose InjSubpotent Drug: found to be below the specification for labeled assay.Advanced Pharma Inc. · D-0113-2018Class IITerminatedDec 27, 20170.25% Acetic Acid Irrigation USPPresence of Particulate Matter: identified as polyethylene, which is consistent with the material used to manufacture the contain capB. Braun Medical Inc · D-0112-2018Class IIITerminatedDec 27, 2017Methylphenidate Hydrochloride Extended-release TabletsSubpotent DrugOsmotica Pharmaceutical Corp · D-0111-2018Class IIITerminatedDec 27, 2017Methylphenidate Hydrochloride Extended-release TabletsSubpotent DrugOsmotica Pharmaceutical Corp · D-0110-2018Class IITerminatedDec 20, 2017Riomet (metformin hydrochloride) Oral Solution Cherry Flavored 500 mg /5 mLMicrobial Contamination of Non-Sterile ProductsSun Pharmaceutical Industries, Inc. · D-0109-2018Class IIITerminatedDec 20, 2017Penicillin V Potassium for Oral SolutionFailed Impurities/Degradation Specifications: high out of specification test results obtained for individual and total impurities.Teva Pharmaceuticals USA · D-0108-2018Class IIITerminatedDec 13, 2017Isradapine Capsules USP 2.5 mgFailed Impurities/Degradation SpecificationsElite Laboratories Inc. · D-0107-2018Class ITerminatedDec 13, 2017grande X 5800 capsuleMarketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.Gadget Island, Inc · D-0106-2018Class ITerminatedDec 13, 2017FIFTY SHADES 6000 capsuleMarketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.Gadget Island, Inc · D-0105-2018Class ITerminatedDec 13, 2017PapaZen 3300 capsuleMarketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.Gadget Island, Inc · D-0104-2018Class ITerminatedDec 13, 2017RHINO 7 Platinum 5000Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.Gadget Island, Inc · D-0103-2018Class ITerminatedDec 13, 2017Pravastatin Sodium TabletsLabeling: Label mix-up, the product labeled as Pravastatin sodium tablets 40 mg was filled with Bupropion hydrochloride XL Tablets 300 mg.International Laboratories, Inc. · D-0102-2018Class IITerminatedDec 6, 2017Paroxetine Tablets USPPresence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine TabletsZydus Pharmaceuticals USA Inc · D-0101-2018Class IITerminatedDec 6, 2017Vertra Elemental ResistanceCGMP Deviations: products manufactured in a manner that may impact product quality that includes but is not limited to failed viscosity.Eai-Jr286 Inc · D-0100-2018Class IITerminatedDec 6, 2017Levetiracetam Oral SolutionPresence of foreign substance (screw)Hetero Labs, Ltd. - Unit III · D-0099-2018Class IITerminatedDec 6, 2017Liothyronine Sodium TabletsFailed Dissolution Specifications.Mayne Pharma Inc · D-0098-2018Class IIITerminatedDec 6, 2017Duloxetine Delayed-Release Capsules USPFailed Dissolution SpecificationLupin Pharmaceuticals Inc. · D-0097-2018Class IITerminatedDec 6, 2017Clozapine Tablets USPFailed Tablet/Capsule Specifications; potential presence of broken tablets.Teva Pharmaceuticals USA · D-0096-2018Class IITerminatedDec 6, 2017No.1 Faiza Beauty CreamMarketed Without an Approved NDA/ANDANew Reliance Trading, Inc. · D-0095-2018Class IIITerminatedNov 29, 2017Dexamethasone Sodium Phosphate InjectionFailed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).West-Ward Pharmaceuticals Corp. · D-0094-2018Class IIITerminatedNov 29, 2017Dexamethasone Sodium Phosphate InjectionFailed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).West-Ward Pharmaceuticals Corp. · D-0093-2018Class IITerminatedNov 29, 2017Pravastatin Sodium USPPresence of foreign tablets/capsules: This product lot is being recalled due to a pharmacy complaint where one Duloxetine Delayed Release Capsule, 30mg was found in a...Lupin Limited · D-0092-2018Class IITerminatedNov 29, 2017Paroxetine TabletsPresence of Foreign Tablets/Capsules.Amerisource Health Services · D-0091-2018Class IITerminatedNov 29, 2017Extra Strength Naturally HL Hemorrhoid Numbing with LidocaineGMP Deviations: inadequate manufacturing control processesRidge Properties, LLC · D-0090-2018Class IITerminatedNov 29, 2017Extra Strength Naturally HL Liquid Hemorrhoid Relief GelGMP Deviations: inadequate manufacturing control processesRidge Properties, LLC · D-0089-2018Class IITerminatedNov 29, 2017Extra Strength Naturally HL Hemorrhoid Numbing Spray with LidocaineGMP Deviations: inadequate manufacturing control processesRidge Properties, LLC · D-0088-2018Class IITerminatedNov 29, 2017Extra Strength PreTAT by TAT BALM GelGMP Deviations: inadequate manufacturing control processesRidge Properties, LLC · D-0087-2018Class IITerminatedNov 29, 2017Extra Strength Naturally HL Bed Sore Relief Cream with Added LidocaineGMP Deviations: inadequate manufacturing control processesRidge Properties, LLC · D-0086-2018Class IITerminatedNov 29, 2017Lorazepam TabletsLabeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepamLeading Pharma, LLC · D-0085-2018Class IITerminatedNov 29, 2017No. 1 Faiza Beauty CreamMarketed Without an Approved NDA/ANDAShata Trading, Inc. · D-0084-2018Class IITerminatedNov 29, 2017TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mLCGMP DeviationsUnited Therapeutics Corp. · D-0083-2018Class IIITerminatedNov 22, 2017Meclizine hydrochloride tablets USPMarketed without an approved NDA/ANDA: Bottles were released prior to final approval.Jubilant Cadista Pharmaceuticals, Inc. · D-0082-2018Class IITerminatedNov 22, 2017Urin D/S Tablets Methenamine 81.6 mgSuperpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.Llorens Pharmaceutical Corp. · D-0081-2018Class IITerminatedNov 22, 2017Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mLSuperpotent drug: out of specification result for potencyPharMEDium Services, LLC. · D-0080-2018